Assessment of Heparin Binding Protein for the Prediction of Severe Sepsis

Status unconfirmed

Conditions studied: Sepsis, Septic Shock, Sepsis With Acute Organ Dysfunction

In brief

The purpose of this prospective, non-interventional, multi-centre clinical study is to assess the clinical validity of the Heparin Binding Protein (HBP) assay for indicating the presence, or outcome, of severe sepsis (including septic shock), over 72 hours, in patients with suspected infection following emergency department admission.

Key facts

Study ID

NCT03113721

Run by

Axis Shield Diagnostics Ltd

People needed

571

Starts

2017-03-27

Expected to finish

2019-03-01

Last updated by the study team

2019-01-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• >18 years of age, suspected infection

You may not qualify if…

• None

Where it is running

• Drexel University — Philadelphia, Pennsylvania, United States
• Thomas Jefferson University — Philadelphia, Pennsylvania, United States
• York Hospitals — York, Pennsylvania, United States
• Vanderbilt University Medical Center — Nashville, Tennessee, United States
• Baylor College of Medicine — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.